SecBot SecBot
SECBOTREPLAY Home › Report › ONCY

ONCY · Oncolytics Biotech announced the appointment of Stephen Glover to its…

ONCOLYTICS BIOTECH INC · 8-K filed Jun 2, 2026 at 09:02 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jun 2, 2026 at 09:02 ET

Oncolytics Biotech announced the appointment of Stephen Glover to its Board of Directors and the promotion of John McAdory to Chief Operating Officer. This is a routine organizational change with no material financial impact.

  • Stephen Glover appointed as independent director, granted option to purchase 96,000 shares vesting over 3 years.
  • John McAdory promoted to COO, previously EVP of Strategy and Operations; no additional compensation.
  • Glover brings public company board and M&A experience, including chairing Ambrx during its $2B acquisition by J&J.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access